Denosumab – a new medication in the treatment of postmenopausal osteoporosis
Osteoporosis is a chronic, systemic skeletal disorder characterised by decreased bone density. It leads to an increased risk of bone fractures – one of the major causes of disability in modern societies. Bisphosphonates are the most commonly used medications in the treatment of postmenopausal oste...
Main Authors: | Radosław Słopień, Piotr Rynio, Elżbieta Kubala, Ewa Milewska, Blazej Meczekalski |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2017-10-01
|
Series: | Menopause Review |
Subjects: | |
Online Access: | https://www.termedia.pl/Denosumab-a-new-medication-in-the-treatment-of-postmenopausal-osteoporosis,4,30778,1,1.html |
Similar Items
-
The Bisphosphonates versus Denosumab Efficiency in Postmenopausal Osteoporosis Treatment
by: Lorena Ciumărnean, et al.
Published: (2017-05-01) -
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01) -
Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series
by: Tsukasa Kobayashi, et al.
Published: (2018-11-01) -
Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
by: Yi Chen, et al.
Published: (2021-04-01) -
Denosumab Treatment of Severe Disuse Osteoporosis in a Boy With Spinal Muscular Atrophy
by: Stepan Kutilek
Published: (2017-12-01)